Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,776 | 602 | 96.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $160.00 | 3 | 1.8% |
| Unspecified | $125.00 | 1 | 1.4% |
| Education | $28.33 | 2 | 0.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,031 | 87 | $0 (2024) |
| Novo Nordisk Inc | $961.88 | 71 | $0 (2024) |
| PFIZER INC. | $853.39 | 68 | $0 (2024) |
| Lilly USA, LLC | $452.49 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $432.27 | 25 | $0 (2024) |
| Amgen Inc. | $430.92 | 32 | $0 (2024) |
| ITI, Inc. | $316.44 | 18 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $272.65 | 17 | $0 (2024) |
| Astellas Pharma US Inc | $246.66 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $237.67 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,022 | 115 | AstraZeneca Pharmaceuticals LP ($248.43) |
| 2023 | $1,299 | 80 | AbbVie Inc. ($229.83) |
| 2022 | $1,327 | 96 | ABBVIE INC. ($308.97) |
| 2021 | $1,046 | 69 | AbbVie Inc. ($233.95) |
| 2020 | $764.30 | 56 | Allergan, Inc. ($137.69) |
| 2019 | $796.45 | 59 | PFIZER INC. ($145.91) |
| 2018 | $850.55 | 66 | Novo Nordisk Inc ($163.18) |
| 2017 | $983.67 | 67 | PFIZER INC. ($195.08) |
All Payment Transactions
608 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: NEUROLOGY | ||||||
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Respiratory | ||||||
| 12/20/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Neurology | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.32 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $122.28 | General |
| Category: NEUROLOGY | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: DIABETES | ||||||
| 11/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $76.70 | General |
| Category: Hematology | ||||||
| 10/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: UROLOGY | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: DIABETES | ||||||
| 10/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: PAIN | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Biological | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 742 | 1,196 | $157,990 | $56,673 |
| 2022 | 10 | 800 | 1,286 | $139,083 | $49,465 |
| 2021 | 11 | 952 | 1,530 | $165,558 | $71,330 |
| 2020 | 13 | 954 | 2,586 | $223,802 | $70,830 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 226 | 363 | $74,778 | $25,065 | 33.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 79 | 79 | $27,018 | $7,999 | 29.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 27 | 27 | $19,143 | $7,326 | 38.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 215 | 516 | $6,192 | $4,334 | 70.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 74 | $10,286 | $4,221 | 41.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 40 | 40 | $6,520 | $2,802 | 43.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 19 | $5,282 | $2,127 | 40.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 41 | 41 | $2,419 | $1,174 | 48.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $4,818 | $880.06 | 18.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 26 | 26 | $1,534 | $744.38 | 48.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 265 | 419 | $85,828 | $28,617 | 33.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 64 | 64 | $16,694 | $7,505 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 90 | $12,367 | $4,384 | 35.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 38 | 38 | $6,194 | $2,605 | 42.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 253 | 560 | $6,720 | $1,640 | 24.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $2,070 | $1,583 | 76.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 46 | 46 | $2,714 | $1,255 | 46.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 15 | $3,954 | $1,028 | 26.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 25 | 25 | $1,475 | $687.63 | 46.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 17 | $1,067 | $160.18 | 15.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 248 | 406 | $76,328 | $28,707 | 37.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 138 | 138 | $32,568 | $17,185 | 52.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 70 | 84 | $21,084 | $9,765 | 46.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 88 | $11,264 | $4,480 | 39.8% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 15 | 15 | $5,190 | $3,357 | 64.7% |
About Dr. David Darr, MD
Dr. David Darr, MD is a Family Medicine healthcare provider based in Warsaw, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447293402.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Darr, MD has received a total of $9,089 in payments from pharmaceutical and medical device companies, with $2,022 received in 2024. These payments were reported across 608 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($8,776).
As a Medicare-enrolled provider, Darr has provided services to 3,448 Medicare beneficiaries, totaling 6,598 services with total Medicare billing of $248,298. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Warsaw, IN
- Active Since 06/14/2006
- Last Updated 09/30/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1447293402
Products in Payments
- VRAYLAR (Drug) $576.84
- CAPLYTA (Drug) $385.77
- JARDIANCE (Drug) $347.33
- Ozempic (Drug) $320.54
- CHANTIX (Drug) $302.90
- UBRELVY (Drug) $290.31
- NURTEC ODT (Drug) $265.40
- Prolia (Biological) $252.59
- QULIPTA (Drug) $223.19
- GEMTESA (Drug) $221.15
- INSPIRE (Device) $210.51
- ELIQUIS (Drug) $205.62
- AIRSUPRA (Drug) $192.26
- ACCRUFER (Drug) $182.26
- Livalo (Drug) $175.32
- Rybelsus (Drug) $169.83
- XARELTO (Drug) $155.52
- Vascepa (Drug) $138.58
- XIFAXAN (Drug) $129.41
- Victoza (Drug) $128.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Warsaw
Dr. Qutubuddin Dar, Md, MD
Family Medicine — Payments: $17,415
Dr. Sydney Domanowski, Do, DO
Family Medicine — Payments: $9,448
Dr. Drew Smith, M.d, M.D
Family Medicine — Payments: $5,827
Tonya Duguid, Do, DO
Family Medicine — Payments: $3,896
Erin Jungbauer, Md, MD
Family Medicine — Payments: $3,146
Brian Reichenbach, M.d, M.D
Family Medicine — Payments: $2,948